Probiotics: A brief overview and why delivery matters for clinical efficacy

Abstract

The human gut microbiome is a diverse ecosystem of more than 40 trillion microorganisms that play an essential role in maintaining health. Disruptions in the gut microbiota, or dysbiosis, are linked to gastrointestinal disorders like inflammatory bowel disease and irritable bowel syndrome, as well as metabolic and immune-mediated conditions including obesity and diabetes.

Probiotics, defined as live microorganisms that confer health benefits when administered in adequate amounts, can help restore microbial balance. They act through mechanisms that include modulation of immune responses, inhibition of pathogens, and production of beneficial metabolites such as short-chain fatty acids. Prebiotics, in turn, are nondigestible food ingredients that selectively stimulate the growth or activity of beneficial bacteria, while synbiotics combine both components for synergistic effects. Probiotic efficacy depends on strain specificity, viability, and delivery. Because probiotics are sensitive to heat, oxygen, and gastric acidity, encapsulation technologies have been developed to enhance survival. Probitec, a health supplement containing 15 billion CFUs of Lactobacillus acidophilus La-14, employs DUOCAP™ dual-capsule technology to protect the probiotic from gastric acid and ensure targeted intestinal release for optimal gut health benefits.